Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$357K | -40K | -100% | $8.93 | 0 | Aug 27, 2021 | Common Stock | 40K | $0.32 | Direct | F1 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$158K | -20K | -100% | $7.88 | 0 | Aug 27, 2021 | Common Stock | 20K | $1.37 | Direct | F2 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -35K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 35K | $15.41 | Direct | F3 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$101K | -44K | -100% | $2.29* | 0 | Aug 27, 2021 | Common Stock | 44K | $6.96 | Direct | F4 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$255K | -44K | -100% | $5.80 | 0 | Aug 27, 2021 | Common Stock | 44K | $3.45 | Direct | F5 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$142K | -49.9K | -100% | $2.85 | 0 | Aug 27, 2021 | Common Stock | 49.9K | $6.40 | Direct | F6 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$37.5K | -75K | -100% | $0.50* | 0 | Aug 27, 2021 | Common Stock | 75K | $8.75 | Direct | F7 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -50K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 50K | $9.91 | Direct | F8 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -50K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 50K | $9.84 | Direct | F9 |
transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$241K | -50K | -100% | $4.81 | 0 | Aug 27, 2021 | Common Stock | 50K | $4.44 | Direct | F10 |
Ervin Veszpremi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | This option, which vested 25% of the total number of shares underlying the option ("Option Shares") on the annual anniversary of January 1, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued service as director on each such vesting date, was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for a cash payment of $357,200.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F2 | This option, which vested 25% of the Option Shares on the annual anniversary of August 29, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued service as director on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $157,600.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F3 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
F4 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $100,760.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F5 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $255,200.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F6 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $142,215.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F7 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $37,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
F8 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
F9 | This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
F10 | This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $240,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |